Home/Filings/4/0001127602-25-004243
4//SEC Filing

Izzar Rachid 4

Accession 0001127602-25-004243

CIK 0000875045other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 9:52 PM ET

Size

13.5 KB

Accession

0001127602-25-004243

Insider Transaction Report

Form 4
Period: 2025-02-07
Izzar Rachid
Head of Global Product Strat.
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-072,0432,044 total
    Exercise: $0.00Exp: 2026-02-08Common Stock (2,043 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-071,8013,604 total
    Exercise: $0.00Exp: 2027-02-07Common Stock (1,801 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-07+2,0437,224 total
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh565$79,8636,059 total
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh600$84,8106,624 total
  • Exercise/Conversion

    Common Stock

    2025-02-07+1,8017,860 total
Footnotes (3)
  • [F1]Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.
  • [F2]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.
  • [F3]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001875506

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:52 PM ET
Size
13.5 KB